Top Story
Health EquityCVS and Walgreens, the two largest pharmacy chains in the United States, announced plans to dispense the abortion pill mifepristone starting this month in select states. This move, enabled by Food and Drug Administration (FDA) certification under revised guidelines, represents a significant step towards improving access [...]
Latest Stories
Featured Webinars
Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping
Thursday, May 23, 2024
Sponsor: OM1
Insights from the 2024 Salary Survey Report by HealthEconomics.com
Wednesday, May 1, 2024
Webinar Host: Scientist.com
The live session will focus on the latest salary and bonus trends for professionals in the field, including a comprehensive overview [...]
Beyond Accelerated Approvals: External Control Arms
Wednesday, April 10, 2024
Sponsor: Cardinal Health
Delphi Panels: What Are They Good For?
Tuesday, March 12, 2024
Sponsor: Partnership for Health Analytic Research (PHAR)
Handpicked Promotions & Highlights
Latest in Catalyst News powered by BioPharmCatalyst
04/24/2024 04:44 PM ET
Cyclacel Pharmaceuticals TNXP date announcement
Tonix Pharmaceuticals Holding now has three catalyst announcements on the calendar after revealing the date on which they will release trial results for Tonmya (TNX-102 SL) - (RELIEF/RESILIENT). Tonix Pharmaceuticals Holding plans to announce top-line [...]
Read More
04/24/2024 04:44 PM ET
Immutep Limited IMMP date announcement
Immutep Limited has an announcement scheduled for June 30, 2024 regarding their recent Phase 2b trial of Eftilagimod alpha (IMP321) and KEYTRUDA (pembrolizumab) - (TACTI-003). Our predictive system gives the drug a 33.7% chance of [...]
Read More
04/24/2024 04:44 PM ET
Affimed N.V. AFMD date announcement
Affimed N.V. now has four catalyst announcements on the calendar after revealing the date on which they will release trial results for AFM24-102 and TECENTRIQ (atezolizumab). Now that the Phase 1/2 trial is completed, Affimed [...]
Read MoreSearch HealthEconomics.com
Throw in a keyword, research topic, disease model or technology of interest